<DOC>
	<DOCNO>NCT01224015</DOCNO>
	<brief_summary>This study evaluate safety efficacy botulinum toxin type A compare placebo treatment Crow 's Feet Lines Frown Lines ( Facial Rhytides ) patient successfully complete Study 191622-099 .</brief_summary>
	<brief_title>Safety Efficacy Study Botulinum Toxin Type A Treatment Crow 's Feet Lines Frown Lines</brief_title>
	<detailed_description />
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Successfully complete Study 191622099 Known immunization hypersensitivity botulinum toxin serotype Anticipated need treatment botulinum toxin serotype study ( except study treatment ) Diagnosis myasthenia gravis , EatonLambert syndrome , amyotrophic lateral sclerosis Anticipated need surgery hospitalization study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>